Copyright
©The Author(s) 2017.
World J Diabetes. Mar 15, 2017; 8(3): 89-96
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.89
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.89
Condition | Glucose control recommendation | Studies with patient number | Ref. |
Non-diabetic ICU patients | 140-180 mg/dL | 29 studies with 8432 total patients and 26 studies with 13567 total patients | Wiener et al[30] (2008) and Griesdale et al[31] (2009), respectively |
Diabetic ICU patients | If HbA1c < 7%: 140-180 mg/dL | 1 retrospective study with 415 total patients | Egi et al[34] (2011) |
If HbA1c > 7%: > 200 mg/dL | |||
Surgical ICU | If ICU stay is for more than 3 d, ventilator dependent, on dialysis, or with cardiac comorbidities: < 150 mg/dL | 1 prospective study with 4864 total patients across 17 yr | Furnary et al[40] (2004) |
Neurocritical ICU patients | If not: < 180 mg/dL | 16 studies with 1258 total patients | Kramer et al[43] (2012) |
If hypoglycemia can be prevented: 110-140 mg/dL | |||
If not: 140-180 mg/dL | |||
STEMI ICU patients | < 200 mg/dL | No high quality studies available Consensus by NICE | Nice Guidelines[47] (2011) |
Sepsis ICU patients | < 180 mg/dL | 1 randomized control trial with 6104 patients | Based of NICE-SUGAR study[17] |
Pregnant ICU patients | No consensus | N/A | Van de Velde et al[55] (2013) |
- Citation: Silva-Perez LJ, Benitez-Lopez MA, Varon J, Surani S. Management of critically ill patients with diabetes. World J Diabetes 2017; 8(3): 89-96
- URL: https://www.wjgnet.com/1948-9358/full/v8/i3/89.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i3.89